Swansea MSc Nanomedicine

What is Swansea MSc Nanomedicine?

Swansea MSc Nanomedicine is a 1 year, full-time programme in nanomaterials, drug delivery and biomedical applications. The September 2027 international tuition is GBP 25,100, and the minimum funding checkpoint shown here is INR 47.49 lakh. Teaching takes place at Singleton Park Campus.

At Singleton Park Campus, the published route runs for 1 year and the module table totals 180 UK credits. Fees and entry rules here belong to the September 2027 full-time cycle.

What funding checkpoint applies to Swansea MSc Nanomedicine?

The September 2027 course page states tuition of GBP 25,100. The outside-London visa rule adds nine months of maintenance evidence, not a full-year living budget. The subtotal below also includes the visa and health charges, so it is a funding checkpoint rather than a complete spending forecast.

The nine-month maintenance amount is evidence of funds, not a Swansea charge, a full-year living budget or a spending guarantee. INR values use GBP 1 = INR 127.0981, the Bank of England spot observation for 23 October 2026. Bank margins and later fee changes are excluded.

The official course page gives one controlling September 2027 international tuition figure of GBP 25,100. The plan does not replace it with a faculty average or a cheaper UK fee.

The maintenance row uses the current outside-London Student route minimum of GBP 1,171 a month for up to nine months. It is a visa evidence floor rather than a twelve-month forecast that rent, food and transport will fit within GBP 10,539.

The subtotal excludes living costs beyond the nine-month evidence period, flights, refundable housing deposits, optional materials and foreign-exchange margins. Swansea currently lists a GBP 4,000 Thrive Bursary for eligible self-funded postgraduate students domiciled in India, but only a written award should be deducted.

The Bank of England observation is a dated conversion checkpoint; it won’t protect the budget from later currency movement or bank charges.

The UKCISA financial-evidence guidance explains that supporting money documents must meet specific rules. This subtotal can’t guarantee that a bank record satisfies them.

Can an Indian applicant meet Swansea MSc Nanomedicine entry rules?

The programme page sets a 2:2 academic threshold and the additional conditions shown below. Swansea’s India equivalence table maps that level to 55% or CGPA 6.1/10 for a minimum three-year bachelor’s degree. The English evidence policy applies alongside the exact programme score.

The useful question is not only whether 55% or CGPA 6.1/10 is met, but where the academic record proves capacity for Regenerative Medicine and Nanomedicines, pharmaceuticals and advanced therapeutics. Module descriptions can make that link visible.

Treat language evidence as its own workstream for MSc Nanomedicine. The programme page does not publish its own IELTS profile, so the exact overall and component scores require written confirmation from Swansea. Any accepted alternative must satisfy Swansea’s live evidence and validity rules.

Three checks that decide an Indian file

1. Equivalence and subject fit are different decisions

   The 55% or CGPA 6.1/10 line establishes Swansea’s grade comparison. It does not remove any subject, experience or professional condition written for MSc Nanomedicine.

2. A three-year bachelor's is accepted for equivalence

   Swansea’s India table expressly covers a bachelor’s degree of at least three years. The complete transcript still has to show the programme-specific preparation.

3. The course profile and offer control English evidence

   The programme page does not publish its own IELTS profile, so the exact overall and component scores require written confirmation from Swansea. Any alternative or medium-of-instruction claim has to meet Swansea’s current evidence policy and the conditions in the offer.

4. Programme-specific conditions must be evidenced

   The academic and English rules published for MSc Nanomedicine control; no additional condition is stated here.

How should an Indian student apply for Swansea MSc Nanomedicine?

The September 2027 deadline table sets 28 July for applications, 16 August for documents and 20 August for deposits. Swansea’s application guidance directs residents of eight named Indian states and Pondicherry through a contracted agent. The course page confirms this full-time route.

Course check, international application, offer conditions, CAS, Student visa and enrolment

The allowances are Nbyula planning estimates, not processing times published by Swansea University.

The strongest application evidence connects earlier work to nanomaterials, drug delivery and biomedical applications. It should explain why the named Swansea modules solve a specific gap rather than repeat the university’s general reputation.

Swansea states the restricted route directly.

"Swansea University is only able to process applications received via one of our contracted agents."Swansea postgraduate application guidance

The named Indian states and Pondicherry in the guidance determine when that route applies.

Upload complete and legible academic records, with official translations where needed. If the contracted-agent rule applies to the applicant’s Indian state or territory, start through that route rather than submitting directly. An application remains incomplete while requested evidence is outstanding.

After an offer, meet every academic and English condition before depending on a CAS date. Housing and travel commitments should allow for the Student visa timetable rather than the hoped-for decision date.

What can follow Swansea MSc Nanomedicine?

The published curriculum supports work towards roles such as nanomedicine researcher, formulation scientist or doctoral researcher. The Graduate route rules give 18 months to an eligible master’s graduate applying from 1 January 2027. Neither source supplies a verified course-specific hiring probability.

The nanomedicine researcher, formulation scientist or doctoral researcher direction is an interpretation of the published curriculum, not evidence of recruitment, pay, sponsorship or professional registration.

Treat major assessments as portfolio opportunities: the method, result, and explanation matter more to an employer than a module name on its own.

The published Graduate route can provide 18 months after an eligible master’s application made from January 2027. It does not remove later sponsorship, occupation, salary, or professional checks.

The QAA master’s characteristics statement distinguishes research, specialised or advanced, and professional or practice awards. A master’s title doesn’t by itself establish a particular job or professional status.

Who is a good fit for Swansea MSc Nanomedicine?

The course structure fits someone with preparation for nanomaterials, drug delivery and biomedical applications and a precise use for the final project. Academic readiness, funding, and the intended use of assessed work still need separate evidence before the programme belongs on a shortlist.

Good fit is observable: the transcript and work history support MSc Nanomedicine, the budget survives without uncertain earnings, and the intended role makes use of the assessed work.

A course can be interesting without being the right next step. Where preparation for nanomaterials, drug delivery and biomedical applications is thin, a broader conversion or foundation route deserves comparison.

Reject the choice when the intended role needs a professional status, placement or curriculum promise that Swansea has not published for this course.

What does the Swansea MSc Nanomedicine syllabus contain?

The official module catalogue publishes the complete named menu below for the full-time route. Available module codes, credits, statuses and teaching blocks are retained without merging them into invented subject buckets. The selection rules show which combinations form the published 180-credit master’s route.

Published module menu

• Read each row's published status before adding credits; optional modules are alternatives rather than an all-taken list.
• The live course and module catalogues control if a title, status, credit value or teaching block changes.

The named components show how the programme develops nanomaterials, drug delivery and biomedical applications. The final project or dissertation then tests independent work rather than taught-module performance alone.

The row status records whether a module is compulsory, optional, a project or a zero-credit requirement. Follow the published selection rule instead of adding every visible option into a false total.

Module availability can change before registration. Recheck the live catalogue after an offer and use the confirmed selection when planning workload or professional exemptions.

Should an Indian student shortlist Swansea MSc Nanomedicine?

Shortlist it when the published course structure matches prior evidence and a defined need for nanomaterials, drug delivery and biomedical applications. Swansea does not publish a verified programme placement rate or salary series, so curriculum fit matters more than a broad outcome claim.

Shortlist MSc Nanomedicine when earlier study supports nanomaterials, drug delivery and biomedical applications and the programme closes a defined skills gap. Swansea publishes the course structure, but no verified placement rate or salary series for this exact cohort. In practical terms, the assessed coursework and final project must add evidence relevant to the intended roles.

The first rejection condition is professional: The interdisciplinary title does not by itself qualify a graduate for clinical practice or guarantee a specialised nanomedicine role. The second is financial: INR 47.49 lakh excludes flights, housing deposits, and exchange movement, so uncertain earnings cannot be the balancing item.

Sources

These sources support the programme, admission, cost and immigration information used on this page.

Sources checked on October 28, 2026. The next intake covered here is September 2027 entry.